Actively Recruiting
Screening and Secondary Prevention Rheumatic Heart Disease Study
Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2023-08-15
5000
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.
CONDITIONS
Official Title
Screening and Secondary Prevention Rheumatic Heart Disease Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Living in rural communities in Sindh
You will not qualify if you...
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institute of Cardiovascular Diseases (NICVD)
Karachi, Sindh, Pakistan, 75510
Actively Recruiting
Research Team
S
Sabha Bhatti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here